Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | REPLIMUNE GROUP INC REPL | Baker Bros. Advisors LP | 5,768,227 9.990% | 5,768,227 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Baker Bros. Advisors LP | 6,354,608 11.300% | 291,906 (+4.81%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | INOZYME PHARMA INC INZY | Baker Bros. Advisors LP | 2,168,000 5.100% | 2,168,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Baker Bros. Advisors LP | 2,879,825 5.200% | 2,879,825 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Baker Bros. Advisors LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Baker Bros. Advisors LP | 1,545,113 9.000% | 45,900 (+3.06%) | Filing History |
| 2023-02-10 4:29 pm Sale | 2023-01-31 | 13G | OTONOMY INC OTIC | Baker Bros. Advisors LP | 0 0.000% | -3,448,263 (Position Closed) | Filing History |
| 2023-01-17 4:32 pm Purchase | 2023-01-12 | 13D | ACADIA PHARMACEUTICALS INC ACAD | Baker Bros. Advisors LP | 42,306,789 26.100% | 1,138,932 (+2.77%) | Filing History |
| 2022-12-12 4:49 pm Sale | 2022-11-30 | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | Baker Bros. Advisors LP | 0 0.000% | -1,064,659 (Position Closed) | Filing History |
| 2022-11-10 4:35 pm Sale | 2022-10-31 | 13G | OTONOMY INC OTIC | Baker Bros. Advisors LP | 3,448,263 6.100% | -4,396,429 (-56.04%) | Filing History |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Baker Bros. Advisors LP | 6,062,702 10.900% | 2,199,463 (+56.93%) | Filing History |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | Baker Bros. Advisors LP | 4,685,690 9.930% | 1,333,333 (+39.77%) | Filing History |
| 2022-06-13 5:27 pm Purchase | 2022-06-07 | 13D | TALIS BIOMEDICAL CORP COM TLIS | Baker Bros. Advisors LP | 2,500,336 66.400% | 4,389 (+0.18%) | Filing History |
| 2022-06-13 5:23 pm Purchase | 2022-06-08 | 13D | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Baker Bros. Advisors LP | 2,348,967 24.980% | 1,232,500 (+110.39%) | Filing History |
| 2022-06-06 5:10 pm Purchase | 2022-06-03 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 17,353,846 33.400% | 922,755 (+5.62%) | Filing History |
| 2022-05-18 5:23 pm Purchase | 2022-05-16 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 16,431,091 31.600% | 865,023 (+5.56%) | Filing History |
| 2022-05-12 4:45 pm Purchase | 2022-05-10 | 13D | TSCAN THERAPEUTICS INC TCRX | Baker Bros. Advisors LP | 2,784,792 14.700% | 1,359,792 (+95.42%) | Filing History |
| 2022-04-05 5:15 pm Purchase | 2022-03-29 | 13D | IGM BIOSCIENCES INC IGMS | Baker Bros. Advisors LP | 3,169,894 11.600% | 12,110 (+0.38%) | Filing History |
| 2022-03-10 5:20 pm Purchase | 2022-03-08 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 36,634,354 16.500% | 1,417,736 (+4.03%) | Filing History |
| 2022-03-10 4:40 pm Sale | 2022-03-08 | 13D | SEATTLE GENETICS INC SGEN | Baker Bros. Advisors LP | 47,223,608 25.700% | -394,895 (-0.83%) | Filing History |